Sign in
CompletedNo phase

Emergency Echocardiography in Sepsis

Key facts

Who runs it
University Hospital, Limoges
Where
France10 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
312 people enrolled
Started
23 Jul 2021
Ended
15 Apr 2025
Type of study
Interventional, 2 groups
Treatments tested
  • early transthoracic echocardiography
  • standards of care
Record updated
21 November 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients admitted to the ED
  • Age ≥ 18 years and affiliation to Social Security
  • With sepsis (Sepsis-3 definition):; Clinically suspected or documented acute infection; AND a quick score Sequential Organ Failure Assessment (qSOFA) ≥ 2 points with:
  • Systolic blood pressure ≤ 100 mmHg (1 point) requiring fluid loading
  • AND encephalopathy (1 point) OR respiratory rate ≥ 22 cpm (1 point) AND a systolic blood pressure ≤ 100 mmHg after 500 mL of crystalloid vascular filling - Informed consent

Who cannot take part

  • Decision to limit care or moribund status
  • Pregnancy or breast feeding
  • Subject under juridical protection

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Acute circulatory failure that combines hypovolemia, vasoplegia and cardiac dysfunction plays a major role in the development of sepsis-related organ dysfunction. Pathophysiological mechanisms are multiple and complex. The objective of the GENESIS study is to determine the impact of early haemodynamic assessment using echocardiography in association with a therapeutic algorithm (intervention arm), when compared with standard of care based on the current Surviving Sepsis Campaign (SSC) recommendations (control arm), on the development of organ dysfunctions in patients admitted to the Emergency Department for sepsis or septic shock.

The 2 groups in the trial

  • Intervention armTreatment being tested

    Assessment using an early transthoracic echocardiography (after 500 mL of fluids) to identify the hemodynamic profile responsible for the acute circulatory failure associated with sepsis / septic shock and to guide ongoing treatment (therapeutic algorithm) and monitor its efficacy and tolerance.

    Treatment: early transthoracic echocardiography

  • Control armOther group

    Conventional management according to current standards of care based on SSC recommendations, including a standardized fluid resuscitation of 30 mL/kg.

    Treatment: standards of care

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Early Haemodynamic Assessment by Echocardiography on Organ Dysfunction of Patients Admitted in the Emergency Department for Sepsis or Septic Shock
Publications
Record updated
21 November 2025